摘要
目的研究分析肝硬化合并上消化道出血患者接受奥曲肽联合埃索美拉唑治疗的临床效果。方法选取2012年2月～2015年2月我院的69例肝硬化合并上消化道出血患者进行研究,将患者分成对照组34例,试验组35例,均使用基础治疗,对照组增加奥曲肽静滴治疗,试验组增加奥曲肽和埃索美拉唑联合治疗,对两组的治疗情况进行比较分析。结果治疗后,试验组的治疗有效率是88.6%,对照组的治疗有效率是61.8%,结果存在统计学差异性（P〈0.05）。结论肝硬化合并上消化道出血可以使用奥曲肽联合埃索美拉唑治疗,疗效突出。
Objective To study the curative effect of Octreotide combine with esomeprazole in treatment of liver cirrhosis with upper gastrointestinal bleeding. Methods Selected 69 cases of hepatocirrhosis with digestive tract hemorrhage from February 2012 to February 2015 in our hospital, which were divided into control group had 34 cases and the experimental group had 35 cases, all of them were use the basic treatment, the control group increased by intravenous drip in treatment with octreotide, the experimental group increased octreotide and esomeprazole combined treatment, the treatment of the two groups were compared and analyzed. Results After treatment, the effective rate of the treatment group was 88.6%, and the effective rate of the control group was 61.8%, and the results were statistically significant（P〈0.05）. Conclusion Hepatic cirrhosis complicated with upper digestive tract hemorrhage octreotide combined with esomeprazole treatment can be used, obvious curative effect, can promote the use.
出处
《中国继续医学教育》
2016年第4期172-173,共2页
China Continuing Medical Education
关键词
肝硬化
上消化道出血
奥曲肽
埃索美拉唑
Liver cirrhosis
Upper gastrointestinal bleeding
Octreotide
Esomeprazole
